Lipocine (LPCN) vs Marker Therapeutics (MRKR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Marker Therapeutics (MRKR) has outperformed Lipocine (LPCN) over the past year, losing 1.9% versus a loss of 31.7%. Over five years, LPCN leads with a -88.5% price change compared with -93.5% for MRKR. Marker Therapeutics is the larger company by market cap ($16.2 million vs $15.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LPCN | MRKR |
|---|---|---|
| Share price | $1.93 | $0.9701 |
| Market cap | $15.91M | $16.17M |
| 1-day change | -12.27% | -6.72% |
| YTD return | -72.60% | -30.20% |
| 1-year return | -31.68% | -1.89% |
| 5-year return | -88.55% | -93.46% |
| EPS (TTM) | $-1.85 | $-0.42 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.37 | $2.46 |
| 52-week low | $1.81 | $0.84 |
| Distance from 52-week high | -84.40% | -60.57% |
| Average volume | 1.68M | 64.80K |
| Shares outstanding | 8.24M | 16.67M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MRKR has outperformed LPCN by 29.8 percentage points over the past year.
LPCN vs MRKR FAQ
Which is bigger, Lipocine or Marker Therapeutics?
Marker Therapeutics (MRKR) is larger, with a market capitalization of $16.17M compared with $15.91M for Lipocine (LPCN).
Which stock has performed better over the past year, LPCN or MRKR?
MRKR returned -1.89% over the past 12 months, compared with -31.68% for LPCN (price return, excluding dividends). Past performance does not predict future results.
Are Lipocine and Marker Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.